Paratek Pharmaceuticals
PRTK
#9350
Rank
S$0.16 B
Marketcap
S$2.88
Share price
0.00%
Change (1 day)
17.13%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -S$60.09 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are S$0.16 Billion. In 2022 the company made an earning of -S$58.7 Million a decrease over its 2021 earnings that were of -S$53.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$60.09 Million2.36%
2022 -S$58.7 Million10.5%
2021 -S$53.12 Million-46.16%
2020 -S$98.67 Million-31.93%
2019 -S$0.15 Billion11.12%
2018 -S$0.14 Billion21.19%
2017 -S$0.11 Billion-23.22%
2016 -S$0.15 Billion54.68%
2015 -S$90.64 Million309.5%
2014 -S$22.14 Million-29.88%
2013 -S$31.57 Million
2011 -S$4.87 Million-59.18%
2010 -S$11.93 Million-53.53%
2009 -S$25.67 Million-161.93%
2008 S$41.43 M-187.43%
2007 -S$47.4 Million11.93%
2006 -S$42.35 Million31.69%
2005 -S$32.16 Million32.4%
2004 -S$24.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-S$0.7 Billion 1,127.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-S$80.02 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$26.71 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA